1. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press. 2009; 18:308–347. PMID:
20001654.
Article
2. Tocci G, Sciarretta S, Volpe M. Development of heart failure in recent hypertension trials. J Hypertens. 2008; 26:1477–1486. PMID:
18551026.
Article
3. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003; 348:2407–2415. PMID:
12802026.
Article
4. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005; 46:156–161. PMID:
15939805.
5. Wei FF, Li Y, Zhang L, Xu TY, Ding FH, Staessen JA, et al. Association of target organ damage with 24-hour systolic and diastolic blood pressure levels and hypertension subtypes in untreated Chinese. Hypertension. 2014; 63:222–228. PMID:
24246384.
Article
6. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens. 2006; 19:243–250. PMID:
16500508.
Article
7. Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension. 2000; 36:894–900. PMID:
11082163.
Article
8. Palatini P, Graniero GR, Canali C, Santonastaso M, Mos L, Piccolo D, et al. Relationship between albumin excretion rate, ambulatory blood pressure and left ventricular hypertrophy in mild hypertension. J Hypertens. 1995; 13(12 Pt 2):1796–1800. PMID:
8903654.
Article
9. Manyari DE. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990; 323:1706–1707. PMID:
2146505.
Article
10. Kalam K, Otahal P, Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart. 2014; 100:1673–1680. PMID:
24860005.
Article
11. Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, et al. Paramount Investigators. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2014; 63:447–456. PMID:
24184245.
Article
12. Na HM, Cho GY, Lee JM, Cha MJ, Yoon YE, Lee SP, et al. Echocardiographic predictors for left ventricular remodeling after acute ST elevation myocardial infarction with low risk group: speckle tracking analysis. J Cardiovasc Ultrasound. 2016; 24:128–134. PMID:
27358705.
Article
13. Pontremoli R, Nicolella C, Viazzi F, Ravera M, Sofia A, Berruti V, et al. Microalbuminuria is an early marker of target organ damage in essential hypertension. Am J Hypertens. 1998; 11(4 Pt 1):430–438. PMID:
9607381.
Article
14. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, BÖhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013; 31:1281–1357. PMID:
23817082.
15. Weber T, O'Rourke MF, Ammer M, Kvas E, Punzengruber C, Eber B. Arterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fraction. Am J Hypertens. 2008; 21:1194–1202. PMID:
18787521.
Article
16. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004; 109:184–189. PMID:
14662706.
Article
17. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003; 107:1401–1406. PMID:
12642361.
18. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Chamber Quantification Writing Group. American Society of Echocardiography's Guidelines and Standards Committee. European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18:1440–1463. PMID:
16376782.
Article
19. Mattix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol. 2002; 13:1034–1039. PMID:
11912263.
Article
20. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015; 16:233–270. PMID:
25712077.
Article
21. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44:837–845. PMID:
3203132.
Article
22. Park S, Kario K, Park CG, Huang QF, Cheng HM, Hoshide S, et al. Characteristics On the ManagEment of Hypertension in Asia-Morning Hypertension Discussion Group (COME Asia MHDG). Target blood pressure in patients with diabetes: Asian perspective. Yonsei Med J. 2016; 57:1307–1311. PMID:
27593856.
Article
23. Armstrong AC, Gidding S, Gjesdal O, Wu C, Bluemke DA, Lima JA. LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice. JACC Cardiovasc Imaging. 2012; 5:837–848. PMID:
22897998.
Article
24. Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, et al. Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation. 2004; 110:2809–2816. PMID:
15492322.
Article
25. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004; 110:921–927. PMID:
15302780.
Article
26. Saito M, Khan F, Stoklosa T, Iannaccone A, Negishi K, Marwick TH. Prognostic implications of LV strain risk score in asymptomatic patients with hypertensive heart disease. JACC Cardiovasc Imaging. 2016; 9:911–921. PMID:
27344417.
27. Narayanan A, Aurigemma GP, Chinali M, Hill JC, Meyer TE, Tighe DA. Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study. Circ Cardiovasc Imaging. 2009; 2:382–390. PMID:
19808626.
28. Imbalzano E, Zito C, Carerj S, Oreto G, Mandraffino G, Cusmà-Piccione M, et al. Left ventricular function in hypertension: new insight by speckle tracking echocardiography. Echocardiography. 2011; 28:649–657. PMID:
21676016.
Article
29. Mizuguchi Y, Oishi Y, Miyoshi H, Iuchi A, Nagase N, Oki T. Concentric left ventricular hypertrophy brings deterioration of systolic longitudinal, circumferential, and radial myocardial deformation in hypertensive patients with preserved left ventricular pump function. J Cardiol. 2010; 55:23–33. PMID:
20122545.
Article
30. Cheng S, Shah AM, Albisu JP, Desai AS, Hilkert RJ, Izzo J, et al. Reversibility of left ventricular mechanical dysfunction in patients with hypertensive heart disease. J Hypertens. 2014; 32:2479–2486. PMID:
25232755.
Article
31. Khattar RS, Swales JD, Dore C, Senior R, Lahiri A. Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation. 2001; 104:783–789. PMID:
11502703.
Article
32. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol. 1971; 27:335–346. PMID:
5572576.
33. Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997; 96:308–315. PMID:
9236450.
34. Sera F, Jin Z, Russo C, Lee ES, Schwartz JE, Rundek T, et al. Relationship of office and ambulatory blood pressure with left ventricular global longitudinal strain. Am J Hypertens. 2016; 29:1261–1267.
Article
35. Eguchi K, Pickering TG, Hoshide S, Ishikawa J, Ishikawa S, Schwartz JE, et al. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens. 2008; 21:443–450. PMID:
18292756.
Article
36. Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA. Predictive role of the nighttime blood pressure. Hypertension. 2011; 57:3–10. PMID:
21079049.
Article
37. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bombelli M, Cuspidi C, et al. Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives. Hypertension. 2008; 52:925–931. PMID:
18779438.
Article
38. Sachdeva A, Weder AB. Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity. Hypertension. 2006; 48:527–533. PMID:
16940213.
Article